2 completed, 2 recruiting, 2 unknown, 1 enrolling by invitation. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Birt-Hogg-Dube Syndrome: new trials by email Literature Review of Birt-Hogg-Dube Syndrome trials Research Report on Birt-Hogg-Dube Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reproductive Options in Inherited Skin Diseases Ichthyosis, Palmoplantar Keratoses | Enrolling by invitation | Maastricht University Medical Center | 650 | 2024-01-01 | 2025-05-18 | |
| Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling Qualitative interview - Quality of Life, Ichthyosis | Recruiting | Maastricht University Medical Center | 25 | 2024-01-01 | 2025-05-18 | |
| Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes Gene test - Renal Tumor Histology, Kidney Cancer | Unknown | RenJi Hospital | 500 | 2022-10-01 | 2023-08-31 | |
| Prevalence of Spontaneous Pneumothorax in BHD CT scan of the thorax, blood sample for FLCN mutation analyses - Spontaneous Pneumothorax | Phase 1 | Unknown | Hans Smit | 200 | 2016-09-01 | 2016-10-26 |
| Assessment of Safety of Air Travel in Patients With Birt-Hogg-Dube Syndrome Non-Interventional Study - Birt-Hogg-Dube Syndrome | Completed | University of Cincinnati | 104 | 2015-08-01 | 2024-01-31 | |
| Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer Everolimus - Renal Cancer, Birt-Hogg-Dube Syndrome | Phase 2 | Terminated | National Cancer Institute (NCI) | 3 | 2015-07-21 | 2019-03-22 |
| MyVHL: Patient Natural History Study Von Hippel-Lindau Disease, Hereditary Leiomyomatosis and Renal Cell Cancer | Recruiting | Joshua Mann, MPH | 10000 | 2012-01-01 | 2024-04-26 | |
| Topical Rapamycin for Fibrofolliculomas Rapamycin, placebo - Birt-Hogg-Dubé Syndrome | Phase 3 | Completed | Maastricht University Medical Center | 19 | 2010-01-01 | 2012-03-08 |
Albinism (2) · Basal Cell Nevus Syndrome (2) · Cutis Laxa (2) · Ectodermal Dysplasia (2) · Epidermolysis Bullosa (2) · Hereditary leiomyomatosis and renal cell cancer (2) · Ichthyosis (2) · Keratoderma, Palmoplantar (2) · Kidney Neoplasms (2) · Tuberous Sclerosis (2) · von Hippel-Lindau Disease (2) · Carcinoma, Renal Cell (1) · Cystic Disease Of Lung (1) · Genetic Diseases, Inborn (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (8) · Neoplasms (8) · Genetic Diseases, Inborn (7) · Neoplastic Syndromes, Hereditary (7) · Abnormalities, Multiple (4) · Congenital Abnormalities (4) · Nervous System Diseases (4) · Neurocutaneous Syndromes (4) · Carcinoma (3) · Neoplasms by Histologic Type (3) · Neoplasms, Glandular and Epithelial (3) · Amino Acid Metabolism, Inborn Errors (2) · Angiomatosis (2) · Bone Cysts (2) · Bone Diseases (2)
Blood Specimen Collection (1) · Everolimus (1) · Sirolimus (1)
Maastricht University Medical Center (3) · Hans Smit (1) · Joshua Mann, MPH (1) · National Cancer Institute (NCI) (1) · RenJi Hospital (1) · University of Cincinnati (1)
Netherlands (4) · United States (3) · China (1)
Antoni Gostynski, MD, PhD (2) · Hans JM Smit, MD, PhD (1) · Jin Zhang (1) · Joshua Mann, MPH (1) · Maurice van Steensel, Dr. (1) · Nishant Gupta, MD (1) · Pieter E. Postmus, MD, PhD (1) · Ramaprasad Srinivasan, M.D. (1)
PMID 24910976, PMID 34783716, PMID 36028846
U54HL127672 (1)